Introduction to the Bivalent Vaccine Market The United States recombinant human papillomavirus (HPV) bivalent vaccine market is an essential segment within the broader vaccine landscape. This vaccine specifically targets two high-risk HPV types, namely HPV 16 and HPV 18, which are responsible for a significant proportion of cervical cancer cases. […]
Recent News